Between Sept. 21 and Sept. 27, Strategy acquired 1,665 Bitcoin at an average price of $85,681 each, increasing its total holdings to 847,666 BTC valued at approximately $63.95 billion. The company financed this purchase partly by selling $246.2 million in common stock and repurchasing $151.7 million in preferred stock, while maintaining $6.02 billion in USD assets. This continued accumulation of Bitcoin occurs as the price trades lower, signaling Strategy's commitment to long-term investment despite market fluctuations.
Strategy's Bitcoin holdings rose by 1,665 BTC, reaching 847,666 BTC as of September 28, 2026. For readers following cryptocurrency, here is Pluang's market snapshot as of Sep 28, 2026 18:21 WIB: out of 50 major cryptocurrencies, 9 rose and 40 fell. Notable movers include BAT at Rp1.609 with a 1-day change of -7.71%, AXS at Rp19.883 down 6.67%, and KSM at Rp81.803 down 6.41%.
Paramount Skydance Corporation has extended the expiration dates for its cash tender and exchange offers on various notes issued by Warner Bros. Discovery entities to October 6, 2026. This extension aligns the settlement dates with the anticipated cl...
Paramount Skydance Corporation announced plans to offer $44.4 billion in senior secured notes to qualified institutional buyers to help finance its acquisition of Warner Bros. Discovery and repay existing debt. The offering includes U.S. dollar- and ...
The Federal Reserve has increased its benchmark interest rate to a range of 3.75% to 4.00%, the first hike since 2023, with another possible before year-end. This move makes high-yield savings accounts more attractive, as they offer significantly hig...
Cellebrite DI Ltd. is under investigation by Kaplan Fox & Kilsheimer LLP for potential securities violations after the company missed its second-quarter revenue targets and cut its full-year guidance. The company reported $507.8 million in annual rec...
TransCode Therapeutics announced updated Phase 1a trial results for TTX-MC138, an RNA-based cancer therapy targeting advanced solid tumors. Among 14 evaluable patients, 71.4% achieved stable disease, with over half maintaining control through three m...
